The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-aminohexadecanoic acid ID: ALA210903
Cas Number: 7769-79-1
PubChem CID: 409322
Product Number: A477134, Order Now?
Max Phase: Preclinical
Molecular Formula: C16H33NO2
Molecular Weight: 271.44
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Synonyms: 2-Aminohexadecanoic Acid | 2-Aminohexadecanoic acid|7769-79-1|2-amino-hexadecanoic acid|CHEBI:63776|Hexadecanoic acid, 2-amino-, (1)-|2-Aminopalmitic acid|2-Aminoctanoic acid|C16 lipoamino acid|2-Aminohexadecanoicacid|alpha-aminopalmitic acid|C16 Laa|alpha-amino hexadecanoic acid|CHEMBL210903|SCHEMBL1738925|DTXSID60328318|XELWBYCKQCNAGY-UHFFFAOYSA-N|LMFA01100018|AKOS015843158|AM82442|AS-58336|CS-0331074|FT-0636595|FT-0695522|NS00076851|A839163|2-Aminohexadecanoic acid, technical, >=95% (NT)|J-50 Show More⌵
Canonical SMILES: CCCCCCCCCCCCCCC(N)C(=O)O
Standard InChI: InChI=1S/C16H33NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15(17)16(18)19/h15H,2-14,17H2,1H3,(H,18,19)
Standard InChI Key: XELWBYCKQCNAGY-UHFFFAOYSA-N
Molfile:
RDKit 2D
19 18 0 0 0 0 0 0 0 0999 V2000
-1.6217 -19.7031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9070 -20.1152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1962 -19.7031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5185 -20.1152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2331 -19.7031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9478 -20.1152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6624 -19.7031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3732 -20.1152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0879 -19.7031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8026 -20.1152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5172 -19.7031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2319 -20.1152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9427 -19.7031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6575 -20.1152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3721 -19.7031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0868 -20.1152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3364 -20.1152 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.6217 -18.8787 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.9061 -20.9395 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
1 17 1 0
1 18 2 0
1 2 1 0
2 19 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 271.44Molecular Weight (Monoisotopic): 271.2511AlogP: 4.49#Rotatable Bonds: 14Polar Surface Area: 63.32Molecular Species: ZWITTERIONHBA: 2HBD: 2#RO5 Violations: ┄HBA (Lipinski): 3HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 2.68CX Basic pKa: 9.53CX LogP: 3.02CX LogD: 3.01Aromatic Rings: ┄Heavy Atoms: 19QED Weighted: 0.46Np Likeness Score: 0.71
References 1. Basse N, Papapostolou D, Pagano M, Reboud-Ravaux M, Bernard E, Felten AS, Vanderesse R.. (2006) Development of lipopeptides for inhibiting 20S proteasomes., 16 (12): [PMID:16630721 ] [10.1016/j.bmcl.2006.03.033 ]